Comparing GHK-Cu discontinuation to other treatments Understanding GHK-Cu discontinuation effects requires comparison to alternative anti-aging treatments revealing whether copper peptide dependency patterns prove more or less favorable than established interventions, helping users make informed decisions about treatment selection, cycling strategies, and long-term maintenance approaches balancing efficacy, safety, cost, and sustainability considerations
Comparing Glutathione Injections and Oral Supplementation When deciding between glutathione injections and oral supplementation, weigh the benefits, drawbacks, and suitability for your specific needs
Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb
CK-treatment increased 3.5-fold the permeability of albumin across the BBB model The penetration of the large biomolecule albumin showed similar pattern to the SF results with only two important significant differences
CJC-1295 with DAC significantly prolongs half-life and GH release duration compared to versions without DAC (Teichman et al., Clinical Pharmacology & Therapeutics )
Oral and capsule versions are less studied and may require higher doses for comparable results